ArticleVaccines2021

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.

Michiel van Diepen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.